Log in
Enquire now
‌

US Patent 6890555 Liposome compositions of porphyrin photosensitizers

Patent 6890555 was granted and assigned to Qlt Inc. on May, 2005 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
0
Current Assignee
‌
Qlt Inc.
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
68905550
Patent Inventor Names
Bushra J. Agha0
James R. Lawter0
Kalidas Madhavrao Kale0
Narendra Raghunathji Desai0
Date of Patent
May 10, 2005
0
Patent Application Number
095893580
Date Filed
June 8, 2000
0
Patent Citations Received
‌
US Patent 12016873 Methods for treating pulmonary non-tuberculous mycobacterial infections
0
Patent Primary Examiner
‌
Gollamudi S. Kishore
0
Patent abstract

Liposomal pharmaceutical formulations incorporating porphyrin photosensitizers useful for photodynamic therapy or diagnosis of malignant cells. The liposomal formulations comprise a porphyrin photosensitizer, particularly the hydro-mono benzoporphyrine (BPD) having light absorption maxima in the range of 670-780 nanometers, a disaccharide or polysaccharide and one or more phospholipids.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 6890555 Liposome compositions of porphyrin photosensitizers

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.